AXT Surges 16.79% on $400M Volume as 350th-Most-Traded Amid AI Expansion Push and Export Permit Delays

Market Snapshot

AXT (AXTI) surged 16.79% on February 25, 2026, with a trading volume of $0.40 billion, ranking 350th in market activity for the day. Despite reporting a fourth-quarter 2025 net loss of $3.55 million and a full-year loss of $21.26 million, the stock’s sharp rise reflects investor optimism driven by the company’s strategic moves to expand production capacity and capitalize on growing demand for indium phosphide wafers in AI and data center applications. The gains occurred against a backdrop of mixed earnings performance and ongoing operational challenges, including export permit delays in China.

Key Drivers

AXT’s stock performance was primarily fueled by its announcement to double indium phosphide wafer manufacturing capacity by the end of 2026, with a 25% expansion already completed since October 2025. Management highlighted robust demand for the material, which is critical for AI infrastructure and high-speed data transmission, as a key catalyst. This capacity ramp is positioned to address anticipated growth in 6-inch indium phosphide wafers and co-packaged optics, sectors where AXT holds a niche but strategic market position. However, the company’s ability to convert this demand into revenue remains contingent on resolving export permit bottlenecks in China, a recurring risk that has historically constrained shipments and revenue recognition.

The earnings report, while showing narrowed quarterly losses, underscored persistent profitability challenges. Full-year 2025 revenue of $88.33 million fell short of expectations, with losses widening to $21.26 million. Analysts have pointed to customer concentration and export permit risks as major headwinds. For instance, delays in Chinese permits have limited AXT’s ability to fulfill orders from key clients, creating revenue volatility. The company’s plans to expand capacity amplify these risks, as higher fixed costs could exacerbate margin pressures if demand or export approvals fail to materialize as projected.

Investor sentiment was further shaped by diverging forecasts for AXT’s long-term prospects. The company’s narrative projects $117.8 million in revenue and $16.6 million in earnings by 2028, implying a potential path to profitability. However, this contrasts with more cautious estimates, such as Simply Wall St’s $9.50 fair value estimate—a 67% discount to the current price. The disparity reflects uncertainty around execution risks, including the scalability of capacity expansions and the company’s ability to secure long-term contracts. Additionally, mixed analyst sentiment highlights the tension between near-term operational hurdles and the long-term potential of AI-driven demand.

The stock’s 63.39% 30-day return, as of February 2026, suggests strong short-term momentum, but this has not been matched by consistent earnings progress. AXT’s valuation remains contentious: while the stock trades near the $28.25 analyst target, its fundamentals include a history of losses and unresolved export challenges. The company’s focus on the STAR Market listing for its Tongmei subsidiary also introduces structural uncertainty, as changes in ownership or capital structure could alter its financial dynamics.

Ultimately, the surge in AXT’s stock underscores investor willingness to bet on the AI infrastructure boom, despite the company’s operational risks. The key question for shareholders is whether the capacity expansion can be executed smoothly, permits in China can be secured promptly, and demand for indium phosphide can scale sufficiently to offset costs. For now, the stock’s performance reflects a balance between high-risk, high-reward potential and the tangible challenges of translating market trends into consistent revenue and profitability.